SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13,342.38 |
| Enterprise Value ($M) | 23,388.29 |
| Book Value ($M) | 10,258.47 |
| Book Value / Share | 23.09 |
| Price / Book | 1.30 |
| NCAV ($M) | -5,989.58 |
| NCAV / Share | -13.48 |
| Price / NCAV | -2.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.54 |
| Current Ratio | 1.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,794.19 |
| Assets | 18,042.24 |
| Liabilities | 7,783.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 8.20 | -11.28 | |
| 13D/A | Severgnini Achille G. | 9.20 | ||
| 13G/A | Vanguard Group Inc | 8.54 | 6.65 | |
| 13G/A | General Atlantic Llc | 5.60 | 0.05 | |
| 13G/A | Fmr Llc | 7.10 | -28.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,638,281 | 4,007,256 | 40.88 | |
| 2,116,115 | 5,183,433 | 40.82 | |
| 1,755,536 | 7,094,200 | 24.75 | |
| 2,101,916 | 6,969,503 | 30.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RLMD – Relmada Therapeutics, Inc. | RLYB – Rallybio Corporation |
| ROIV – Roivant Sciences Ltd. | RPTX – Repare Therapeutics Inc. |
| RVMD – Revolution Medicines, Inc. |
Financial data and stock pages provided by
Fintel.io